Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06071104 · ClinicalTrials.gov registry record · NA

Next Generation Cataract Surgery Study

A NA study, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT06071104 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06071104, a NA study, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect user preference data.

Interventions

  • PROCEDURE Anterior segment ophthalmic surgery
  • DEVICE UNITY VCS

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2023-12-06
Est. Completion 2024-06-28
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT06071104

The ClinicalTrials.gov registry entry for NCT06071104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Anterior segment ophthalmic surgery is the first listed.

NCT06071104 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06071104 about?

NCT06071104 is a clinical study titled "Next Generation Cataract Surgery Study". The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect user preference data.

What is the current status of trial NCT06071104?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2023-12-06. Estimated completion is 2024-06-28.

What interventions are being tested in trial NCT06071104?

The interventions under investigation include: Anterior segment ophthalmic surgery (PROCEDURE), UNITY VCS (DEVICE).

Who is sponsoring clinical trial NCT06071104?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.